Body PSOriasis: Long-term Relapse CONTROL
Body PSOriasis: Long-term Relapse CONTROL
This non-interventional study of real-life clinical practice strategies for long-term relapse
 control in patients with psoriasis vulgaris is planned to enroll 650 adult patients from
 60-100 Russian dermatology sites and follow the patients for up to 52 weeks. The study will
 map actual strategies and focus on patients' and dermatologists' experience with the
 different topicals used, including unspecified products with and without active drugs.
Inclusion Criteria:

 -  Patients planned to receive topical treatment of any kind to prevent relapse of
 symptoms

 -  Written informed consent

 Exclusion Criteria:

 -  Contraindications to selected treatment

 -  Ongoing systemic treatment of psoriasis with steroids, anti-inflammatory drugs or
 phototherapy